Treace Share Price

Treace Share Price

NASDAQ: TMCI | Micro Cap | Healthcare
$4.32
-$0.09 (-2.15%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Treace Stock Performance

Open
$4.25
Prev. Close
$4.41
Circuit Range
N/A
Day Range
$4.25 - $4.38
Year Range
$1.18 - $5.40
Volume
15,016
Average Traded
$4.32

Treace Share Price Today

As of 21 November 2026, Treace Medical Concepts, Inc.'s share price is $4.32. The stock opened at $4.25, compared to its previous close of $4.41. During today's trading session, Treace Medical Concepts, Inc.'s share price traded between $4.25 and $4.38, with an average price of $4.31. Over the past 52 weeks, the stock has recorded a high of $5.40 and a low of $1.18. In terms of performance, Treace Medical Concepts, Inc.'s share price has risen by 24.53% over the last six months and is up 44.56% on a year-on-year basis.

Treace Share Price Chart

Line chart of the Treace price trend over the selected period. The price fell overall, ranging from 4.23 to 4.42, ending at 4.32.
$4.25$4.38
L
Show Current Price
H

Treace Stock Fundamentals & Key Indicators

Market Cap
$273.01M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.85
Revenue (TTM)
$212.69B
Return On Equity (TTM)
-90.60%
Profit Margin
-27.74%
Debt to Equity
0.91
Quarterly Earnings Growth YoY
-34.40%

Treace Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$62.52$47.20$45.38$48.25
Net Profit-$9.39-$17.96-$15.87-$12.62
Net Profit Margin-15.02%-38.05%-34.97%-26.16%
Income ChangeN/A-91.27%11.64%20.48%

Treace Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$141.84$187.12$209.36$212.69
Net Profit-$42.82-$49.53-$55.74-$59.00
Net Profit Margin-30.19%-26.47%-26.62%-27.74%
Income ChangeN/A-15.67%-12.54%-5.85%

Treace Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets58.5355.6953.5525.62
Current Assets132.05161.4198.36133.4
Total Assets190.58217.09251.91159.02
Non Current Liabilities72.6169.2868.9468.25
Current Liabilities30.6434.9345.0330.25
Total Liabilities103.25104.2113.9798.5
Shareholders' Equity87.33112.89137.9460.53

Treace Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-15.97-37.17-34.58-30.65
Investing13.2535.38-81.3-76.52
Financing2.080.16109.3820.81

About Treace

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Treace Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.68
$4.31
-2.38%
Oct 2026
$4.41
$4.42
-0.90%
Sep 2026
$4.64
$4.46
-3.36%
Aug 2026
$4.36
$4.61
+7.08%
Jul 2026
$4.03
$4.30
+8.99%
Jun 2026
$3.47
$3.95
+14.00%
May 2026
$1.83
$3.46
+91.44%
Apr 2026
$1.37
$1.81
+35.07%
Mar 2026
$1.81
$1.34
-27.96%
Feb 2026
$2.30
$1.86
-20.17%
Jan 2026
$2.48
$2.33
-4.90%
Dec 2025
$2.97
$2.45
-17.92%

Treace Share Price FAQs